Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 12, 2019
Patent Application Number
15802142
Date Filed
November 2, 2017
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
The present disclosure relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.